outpatient management of car-t therapy in multiple myeloma and lymphoma
Published 6 months ago • 81 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
2:18
feasibility of outpatient practice for car-t therapy in patients with lymphoma and multiple myeloma
-
0:46
challenges associated with the use of off-the-shelf car-t products in multiple myeloma
-
1:26
feasibility and safety of outpatient practice for recently approved car-t therapies
-
4:12
car-t therapy in multiple myeloma: recent updates, clinical trials and future outlooks
-
3:06
management of multiple myeloma during car-t therapy manufacturing
-
4:14
challenges with the real-world use of car-t therapy in multiple myeloma
-
2:03
car-t therapy in myeloma: moving into earlier lines and treating patients with unmet medical needs
-
1:12
contemporary challenges in polycythemia vera management
-
1:38
real world use of car t-cell therapy in multiple myeloma
-
9:58
the management & optimization of car t-cell therapy in myeloma
-
1:12
optimizing car-t therapy for patients with multiple myeloma in the real-world
-
3:03
the future of car-t therapy for multiple myeloma
-
1:01
the potentially curative role of car-t therapy in myeloma
-
2:00
the value of car-t cell therapy for the treatment of r/r multiple myeloma
-
2:35
latest advances in car-t for multiple myeloma: cilta-cel & new car-t platforms
-
1:22
the potential use of car-t therapy following autologous transplantation in multiple myeloma
-
1:45
car t-cells in myeloma: patients’ perspective
-
2:01
car-t updates in myeloma
-
2:30
an update on the current status of car-t therapy in multiple myeloma